Industry Research Reports

Home > Reports > Machinery & Equipment > Global PRRS Vaccines Market Research Report 2025

Global PRRS Vaccines Market Research Report 2025

Industry: Machinery & Equipment

Published Date: 2025-05-23

Pages: 115 Pages

Report ld: 4234358

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

PRRS Vaccines Market Size(US$)

CAGR 2025-2031

3.5%

Market Size,2031

USD 527

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 429 million

Market Forecast in 2031(Value)

US$ 527 million

CAGR

3.5%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for PRRS Vaccines was valued at US$ 410 million in the year 2024 and is projected to reach a revised size of US$ 527 million by 2031, growing at a CAGR of 3.5% during the forecast period.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on PRRS Vaccines competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

There are two types of PRRS vaccines that are commercially available. One is a modified-live virus (MLV) vaccine and the other is a killed virus (KV) vaccine. PRRS MLV vaccine is well recognized for its protective efficacy against PRRSV that are genetically homologous to the vaccine virus.Porcine Reproductive and Respiratory Syndrome (PRRS) vaccine is a biological product designed to prevent and control PRRS, a highly contagious viral disease that affects pigs. The vaccine works by stimulating the pig's immune system to produce a protective response against the PRRS virus, thereby reducing reproductive failures such as abortions and stillbirths in sows, as well as respiratory illness and mortality in piglets and growing pigs. PRRS vaccines are typically classified into modified live vaccines (MLVs) and inactivated vaccines, and they play a critical role in improving herd health and productivity in the swine industry worldwide.

The global PRRS vaccine market is primarily driven by the widespread prevalence and economic impact of Porcine Reproductive and Respiratory Syndrome in the swine industry. PRRS is one of the most devastating diseases affecting pigs, causing significant reproductive losses in breeding herds and severe respiratory distress in growing pigs. The virus's ability to mutate and persist in herds has made it difficult to eradicate, leading to chronic infections and substantial financial losses for pig farmers. As a result, governments and veterinary authorities in major pork-producing countries such as China, the United States, and countries in the European Union have emphasized vaccination as a critical component of disease control programs. Additionally, rising global pork consumption is pressuring producers to maintain healthier herds and ensure consistent productivity, further boosting demand for effective PRRS vaccines. Technological advancements in vaccine formulation—such as the development of region-specific or genotype-specific modified live vaccines (MLVs)—have improved vaccine efficacy, making immunization a more reliable and widely accepted preventive measure. Moreover, increasing biosecurity awareness and the integration of vaccination into herd health management systems are reinforcing the growth of the PRRS vaccine market globally.

Despite its importance, the PRRS vaccine market faces several challenges that limit its effectiveness and adoption in certain regions. One of the primary issues is the virus's high genetic variability, which complicates the development of universally effective vaccines. The presence of multiple genotypes and frequent mutations means that vaccine strains may not provide cross-protection against all circulating variants, leading to inconsistent results and partial immunity in vaccinated herds. Additionally, modified live vaccines (MLVs), while generally more effective than inactivated ones, carry risks of reversion to virulence or recombination with field strains, which raises safety concerns among producers and regulatory bodies. In developing regions, limited access to veterinary services, cold chain logistics, and affordability issues further hinder the widespread adoption of PRRS vaccination programs. Moreover, there remains a lack of standardized vaccination protocols across countries, and vaccine performance can vary depending on farm conditions, pig genetics, and co-infections with other pathogens. These factors make disease management complex and can reduce confidence in vaccination strategies. Overcoming these challenges requires continued investment in research and development of next-generation vaccines, improved diagnostic tools for strain identification, and stronger government support for vaccination campaigns and swine health education.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for PRRS Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PRRS Vaccines.

The PRRS Vaccines market size, estimations, and forecasts are provided in terms of output/shipments (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global PRRS Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the PRRS Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

China Animal Husbandry Co., Ltd.

Boehringer Ingelheim

MSD Animal Health

Sinopharm Animal Health

Ceva

Ruipu Biological

Qilu Animal Health

Dahuanong

CAVAC

Komipharm

Agrovet

Bioveta

Jinyu

Phibro Animal Health

Tiankang

Zoetis

Yongshun Biological

Pulike Biological

Segment by Type

Live Vaccines

Killed Vaccines

Segment by Application

Government Tender

Market Sales

Production by Region

North America

Europe

China

Japan

Consumption by Region

North America

U.S.

Canada

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Europe

Germany

France

U.K.

Italy

Russia

Latin America

Mexico

Brazil

Argentina

Middle East and Africa

Turkey

Saudi Arabia

U.A.E

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of PRRS Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Production/output, value of PRRS Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 4: Consumption of PRRS Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 PRRS Vaccines Market Overview

1.1 Product Definition

1.2 PRRS Vaccines by Type

1.2.1 Global PRRS Vaccines Market Value Growth Rate Analysis by Type: 2024 VS 2031

1.2.2 Live Vaccines

1.2.3 Killed Vaccines

1.3 PRRS Vaccines by Application

1.3.1 Global PRRS Vaccines Market Value Growth Rate Analysis by Application: 2024 VS 2031

1.3.2 Government Tender

1.3.3 Market Sales

1.4 Global Market Growth Prospects

1.4.1 Global PRRS Vaccines Production Value Estimates and Forecasts (2020-2031)

1.4.2 Global PRRS Vaccines Production Capacity Estimates and Forecasts (2020-2031)

1.4.3 Global PRRS Vaccines Production Estimates and Forecasts (2020-2031)

1.4.4 Global PRRS Vaccines Market Average Price Estimates and Forecasts (2020-2031)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global PRRS Vaccines Production Market Share by Manufacturers (2020-2025)

2.2 Global PRRS Vaccines Production Value Market Share by Manufacturers (2020-2025)

2.3 Global Key Players of PRRS Vaccines, Industry Ranking, 2023 VS 2024

2.4 Global PRRS Vaccines Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.5 Global PRRS Vaccines Average Price by Manufacturers (2020-2025)

2.6 Global Key Manufacturers of PRRS Vaccines, Manufacturing Base Distribution and Headquarters

2.7 Global Key Manufacturers of PRRS Vaccines, Product Offered and Application

2.8 Global Key Manufacturers of PRRS Vaccines, Date of Enter into This Industry

2.9 PRRS Vaccines Market Competitive Situation and Trends

2.9.1 PRRS Vaccines Market Concentration Rate

2.9.2 Global 5 and 10 Largest PRRS Vaccines Players Market Share by Revenue

2.10 Mergers & Acquisitions, Expansion

3 PRRS Vaccines Production by Region

3.1 Global PRRS Vaccines Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.2 Global PRRS Vaccines Production Value by Region (2020-2031)

3.2.1 Global PRRS Vaccines Production Value by Region (2020-2025)

3.2.2 Global Forecasted Production Value of PRRS Vaccines by Region (2026-2031)

3.3 Global PRRS Vaccines Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.4 Global PRRS Vaccines Production Volume by Region (2020-2031)

3.4.1 Global PRRS Vaccines Production by Region (2020-2025)

3.4.2 Global Forecasted Production of PRRS Vaccines by Region (2026-2031)

3.5 Global PRRS Vaccines Market Price Analysis by Region (2020-2025)

3.6 Global PRRS Vaccines Production and Value, Year-over-Year Growth

3.6.1 North America PRRS Vaccines Production Value Estimates and Forecasts (2020-2031)

3.6.2 Europe PRRS Vaccines Production Value Estimates and Forecasts (2020-2031)

3.6.3 China PRRS Vaccines Production Value Estimates and Forecasts (2020-2031)

3.6.4 Japan PRRS Vaccines Production Value Estimates and Forecasts (2020-2031)

4 PRRS Vaccines Consumption by Region

4.1 Global PRRS Vaccines Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

4.2 Global PRRS Vaccines Consumption by Region (2020-2031)

4.2.1 Global PRRS Vaccines Consumption by Region (2020-2025)

4.2.2 Global PRRS Vaccines Forecasted Consumption by Region (2026-2031)

4.3 North America

4.3.1 North America PRRS Vaccines Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.3.2 North America PRRS Vaccines Consumption by Country (2020-2031)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe PRRS Vaccines Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.4.2 Europe PRRS Vaccines Consumption by Country (2020-2031)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Netherlands

4.5 Asia Pacific

4.5.1 Asia Pacific PRRS Vaccines Consumption Growth Rate by Region: 2020 VS 2024 VS 2031

4.5.2 Asia Pacific PRRS Vaccines Consumption by Region (2020-2031)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa PRRS Vaccines Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.6.2 Latin America, Middle East & Africa PRRS Vaccines Consumption by Country (2020-2031)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global PRRS Vaccines Production by Type (2020-2031)

5.1.1 Global PRRS Vaccines Production by Type (2020-2025)

5.1.2 Global PRRS Vaccines Production by Type (2026-2031)

5.1.3 Global PRRS Vaccines Production Market Share by Type (2020-2031)

5.2 Global PRRS Vaccines Production Value by Type (2020-2031)

5.2.1 Global PRRS Vaccines Production Value by Type (2020-2025)

5.2.2 Global PRRS Vaccines Production Value by Type (2026-2031)

5.2.3 Global PRRS Vaccines Production Value Market Share by Type (2020-2031)

5.3 Global PRRS Vaccines Price by Type (2020-2031)

6 Segment by Application

6.1 Global PRRS Vaccines Production by Application (2020-2031)

6.1.1 Global PRRS Vaccines Production by Application (2020-2025)

6.1.2 Global PRRS Vaccines Production by Application (2026-2031)

6.1.3 Global PRRS Vaccines Production Market Share by Application (2020-2031)

6.2 Global PRRS Vaccines Production Value by Application (2020-2031)

6.2.1 Global PRRS Vaccines Production Value by Application (2020-2025)

6.2.2 Global PRRS Vaccines Production Value by Application (2026-2031)

6.2.3 Global PRRS Vaccines Production Value Market Share by Application (2020-2031)

6.3 Global PRRS Vaccines Price by Application (2020-2031)

7 Key Companies Profiled

7.1 China Animal Husbandry Co., Ltd.

7.1.1 China Animal Husbandry Co., Ltd. PRRS Vaccines Company Information

7.1.2 China Animal Husbandry Co., Ltd. PRRS Vaccines Product Portfolio

7.1.3 China Animal Husbandry Co., Ltd. PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.1.4 China Animal Husbandry Co., Ltd. Main Business and Markets Served

7.1.5 China Animal Husbandry Co., Ltd. Recent Developments/Updates

7.2 Boehringer Ingelheim

7.2.1 Boehringer Ingelheim PRRS Vaccines Company Information

7.2.2 Boehringer Ingelheim PRRS Vaccines Product Portfolio

7.2.3 Boehringer Ingelheim PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.2.4 Boehringer Ingelheim Main Business and Markets Served

7.2.5 Boehringer Ingelheim Recent Developments/Updates

7.3 MSD Animal Health

7.3.1 MSD Animal Health PRRS Vaccines Company Information

7.3.2 MSD Animal Health PRRS Vaccines Product Portfolio

7.3.3 MSD Animal Health PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.3.4 MSD Animal Health Main Business and Markets Served

7.3.5 MSD Animal Health Recent Developments/Updates

7.4 Sinopharm Animal Health

7.4.1 Sinopharm Animal Health PRRS Vaccines Company Information

7.4.2 Sinopharm Animal Health PRRS Vaccines Product Portfolio

7.4.3 Sinopharm Animal Health PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.4.4 Sinopharm Animal Health Main Business and Markets Served

7.4.5 Sinopharm Animal Health Recent Developments/Updates

7.5 Ceva

7.5.1 Ceva PRRS Vaccines Company Information

7.5.2 Ceva PRRS Vaccines Product Portfolio

7.5.3 Ceva PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.5.4 Ceva Main Business and Markets Served

7.5.5 Ceva Recent Developments/Updates

7.6 Ruipu Biological

7.6.1 Ruipu Biological PRRS Vaccines Company Information

7.6.2 Ruipu Biological PRRS Vaccines Product Portfolio

7.6.3 Ruipu Biological PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.6.4 Ruipu Biological Main Business and Markets Served

7.6.5 Ruipu Biological Recent Developments/Updates

7.7 Qilu Animal Health

7.7.1 Qilu Animal Health PRRS Vaccines Company Information

7.7.2 Qilu Animal Health PRRS Vaccines Product Portfolio

7.7.3 Qilu Animal Health PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.7.4 Qilu Animal Health Main Business and Markets Served

7.7.5 Qilu Animal Health Recent Developments/Updates

7.8 Dahuanong

7.8.1 Dahuanong PRRS Vaccines Company Information

7.8.2 Dahuanong PRRS Vaccines Product Portfolio

7.8.3 Dahuanong PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.8.4 Dahuanong Main Business and Markets Served

7.8.5 Dahuanong Recent Developments/Updates

7.9 CAVAC

7.9.1 CAVAC PRRS Vaccines Company Information

7.9.2 CAVAC PRRS Vaccines Product Portfolio

7.9.3 CAVAC PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.9.4 CAVAC Main Business and Markets Served

7.9.5 CAVAC Recent Developments/Updates

7.10 Komipharm

7.10.1 Komipharm PRRS Vaccines Company Information

7.10.2 Komipharm PRRS Vaccines Product Portfolio

7.10.3 Komipharm PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.10.4 Komipharm Main Business and Markets Served

7.10.5 Komipharm Recent Developments/Updates

7.11 Agrovet

7.11.1 Agrovet PRRS Vaccines Company Information

7.11.2 Agrovet PRRS Vaccines Product Portfolio

7.11.3 Agrovet PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.11.4 Agrovet Main Business and Markets Served

7.11.5 Agrovet Recent Developments/Updates

7.12 Bioveta

7.12.1 Bioveta PRRS Vaccines Company Information

7.12.2 Bioveta PRRS Vaccines Product Portfolio

7.12.3 Bioveta PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.12.4 Bioveta Main Business and Markets Served

7.12.5 Bioveta Recent Developments/Updates

7.13 Jinyu

7.13.1 Jinyu PRRS Vaccines Company Information

7.13.2 Jinyu PRRS Vaccines Product Portfolio

7.13.3 Jinyu PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.13.4 Jinyu Main Business and Markets Served

7.13.5 Jinyu Recent Developments/Updates

7.14 Phibro Animal Health

7.14.1 Phibro Animal Health PRRS Vaccines Company Information

7.14.2 Phibro Animal Health PRRS Vaccines Product Portfolio

7.14.3 Phibro Animal Health PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.14.4 Phibro Animal Health Main Business and Markets Served

7.14.5 Phibro Animal Health Recent Developments/Updates

7.15 Tiankang

7.15.1 Tiankang PRRS Vaccines Company Information

7.15.2 Tiankang PRRS Vaccines Product Portfolio

7.15.3 Tiankang PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.15.4 Tiankang Main Business and Markets Served

7.15.5 Tiankang Recent Developments/Updates

7.16 Zoetis

7.16.1 Zoetis PRRS Vaccines Company Information

7.16.2 Zoetis PRRS Vaccines Product Portfolio

7.16.3 Zoetis PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.16.4 Zoetis Main Business and Markets Served

7.16.5 Zoetis Recent Developments/Updates

7.17 Yongshun Biological

7.17.1 Yongshun Biological PRRS Vaccines Company Information

7.17.2 Yongshun Biological PRRS Vaccines Product Portfolio

7.17.3 Yongshun Biological PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.17.4 Yongshun Biological Main Business and Markets Served

7.17.5 Yongshun Biological Recent Developments/Updates

7.18 Pulike Biological

7.18.1 Pulike Biological PRRS Vaccines Company Information

7.18.2 Pulike Biological PRRS Vaccines Product Portfolio

7.18.3 Pulike Biological PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.18.4 Pulike Biological Main Business and Markets Served

7.18.5 Pulike Biological Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 PRRS Vaccines Industry Chain Analysis

8.2 PRRS Vaccines Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 PRRS Vaccines Production Mode & Process Analysis

8.4 PRRS Vaccines Sales and Marketing

8.4.1 PRRS Vaccines Sales Channels

8.4.2 PRRS Vaccines Distributors

8.5 PRRS Vaccines Customer Analysis

9 PRRS Vaccines Market Dynamics

9.1 PRRS Vaccines Industry Trends

9.2 PRRS Vaccines Market Drivers

9.3 PRRS Vaccines Market Challenges

9.4 PRRS Vaccines Market Restraints

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global PRRS Vaccines Market Value by Type, (US$ Million) & (2024 VS 2031)

Table 2. Global PRRS Vaccines Market Value by Application, (US$ Million) & (2024 VS 2031)

Table 3. Global PRRS Vaccines Production Capacity (K Units) by Manufacturers in 2024

Table 4. Global PRRS Vaccines Production by Manufacturers (2020-2025) & (K Units)

Table 5. Global PRRS Vaccines Production Market Share by Manufacturers (2020-2025)

Table 6. Global PRRS Vaccines Production Value by Manufacturers (2020-2025) & (US$ Million)

Table 7. Global PRRS Vaccines Production Value Share by Manufacturers (2020-2025)

Table 8. Global Key Players of PRRS Vaccines, Industry Ranking, 2023 VS 2024

Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in PRRS Vaccines as of 2024)

Table 10. Global Market PRRS Vaccines Average Price by Manufacturers (USD/Unit) & (2020-2025)

Table 11. Global Key Manufacturers of PRRS Vaccines, Manufacturing Base Distribution and Headquarters

Table 12. Global Key Manufacturers of PRRS Vaccines, Product Offered and Application

Table 13. Global Key Manufacturers of PRRS Vaccines, Date of Enter into This Industry

Table 14. Global PRRS Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global PRRS Vaccines Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global PRRS Vaccines Production Value (US$ Million) by Region (2020-2025)

Table 18. Global PRRS Vaccines Production Value Market Share by Region (2020-2025)

Table 19. Global PRRS Vaccines Production Value (US$ Million) Forecast by Region (2026-2031)

Table 20. Global PRRS Vaccines Production Value Market Share Forecast by Region (2026-2031)

Table 21. Global PRRS Vaccines Production Comparison by Region: 2020 VS 2024 VS 2031 (K Units)

Table 22. Global PRRS Vaccines Production (K Units) by Region (2020-2025)

Table 23. Global PRRS Vaccines Production Market Share by Region (2020-2025)

Table 24. Global PRRS Vaccines Production (K Units) Forecast by Region (2026-2031)

Table 25. Global PRRS Vaccines Production Market Share Forecast by Region (2026-2031)

Table 26. Global PRRS Vaccines Market Average Price (USD/Unit) by Region (2020-2025)

Table 27. Global PRRS Vaccines Market Average Price (USD/Unit) by Region (2026-2031)

Table 28. Global PRRS Vaccines Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (K Units)

Table 29. Global PRRS Vaccines Consumption by Region (2020-2025) & (K Units)

Table 30. Global PRRS Vaccines Consumption Market Share by Region (2020-2025)

Table 31. Global PRRS Vaccines Forecasted Consumption by Region (2026-2031) & (K Units)

Table 32. Global PRRS Vaccines Forecasted Consumption Market Share by Region (2026-2031)

Table 33. North America PRRS Vaccines Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)

Table 34. North America PRRS Vaccines Consumption by Country (2020-2025) & (K Units)

Table 35. North America PRRS Vaccines Consumption by Country (2026-2031) & (K Units)

Table 36. Europe PRRS Vaccines Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)

Table 37. Europe PRRS Vaccines Consumption by Country (2020-2025) & (K Units)

Table 38. Europe PRRS Vaccines Consumption by Country (2026-2031) & (K Units)

Table 39. Asia Pacific PRRS Vaccines Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (K Units)

Table 40. Asia Pacific PRRS Vaccines Consumption by Region (2020-2025) & (K Units)

Table 41. Asia Pacific PRRS Vaccines Consumption by Region (2026-2031) & (K Units)

Table 42. Latin America, Middle East & Africa PRRS Vaccines Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)

Table 43. Latin America, Middle East & Africa PRRS Vaccines Consumption by Country (2020-2025) & (K Units)

Table 44. Latin America, Middle East & Africa PRRS Vaccines Consumption by Country (2026-2031) & (K Units)

Table 45. Global PRRS Vaccines Production (K Units) by Type (2020-2025)

Table 46. Global PRRS Vaccines Production (K Units) by Type (2026-2031)

Table 47. Global PRRS Vaccines Production Market Share by Type (2020-2025)

Table 48. Global PRRS Vaccines Production Market Share by Type (2026-2031)

Table 49. Global PRRS Vaccines Production Value (US$ Million) by Type (2020-2025)

Table 50. Global PRRS Vaccines Production Value (US$ Million) by Type (2026-2031)

Table 51. Global PRRS Vaccines Production Value Market Share by Type (2020-2025)

Table 52. Global PRRS Vaccines Production Value Market Share by Type (2026-2031)

Table 53. Global PRRS Vaccines Price (USD/Unit) by Type (2020-2025)

Table 54. Global PRRS Vaccines Price (USD/Unit) by Type (2026-2031)

Table 55. Global PRRS Vaccines Production (K Units) by Application (2020-2025)

Table 56. Global PRRS Vaccines Production (K Units) by Application (2026-2031)

Table 57. Global PRRS Vaccines Production Market Share by Application (2020-2025)

Table 58. Global PRRS Vaccines Production Market Share by Application (2026-2031)

Table 59. Global PRRS Vaccines Production Value (US$ Million) by Application (2020-2025)

Table 60. Global PRRS Vaccines Production Value (US$ Million) by Application (2026-2031)

Table 61. Global PRRS Vaccines Production Value Market Share by Application (2020-2025)

Table 62. Global PRRS Vaccines Production Value Market Share by Application (2026-2031)

Table 63. Global PRRS Vaccines Price (USD/Unit) by Application (2020-2025)

Table 64. Global PRRS Vaccines Price (USD/Unit) by Application (2026-2031)

Table 65. China Animal Husbandry Co., Ltd. PRRS Vaccines Company Information

Table 66. China Animal Husbandry Co., Ltd. PRRS Vaccines Specification and Application

Table 67. China Animal Husbandry Co., Ltd. PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 68. China Animal Husbandry Co., Ltd. Main Business and Markets Served

Table 69. China Animal Husbandry Co., Ltd. Recent Developments/Updates

Table 70. Boehringer Ingelheim PRRS Vaccines Company Information

Table 71. Boehringer Ingelheim PRRS Vaccines Specification and Application

Table 72. Boehringer Ingelheim PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Boehringer Ingelheim Main Business and Markets Served

Table 74. Boehringer Ingelheim Recent Developments/Updates

Table 75. MSD Animal Health PRRS Vaccines Company Information

Table 76. MSD Animal Health PRRS Vaccines Specification and Application

Table 77. MSD Animal Health PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. MSD Animal Health Main Business and Markets Served

Table 79. MSD Animal Health Recent Developments/Updates

Table 80. Sinopharm Animal Health PRRS Vaccines Company Information

Table 81. Sinopharm Animal Health PRRS Vaccines Specification and Application

Table 82. Sinopharm Animal Health PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Sinopharm Animal Health Main Business and Markets Served

Table 84. Sinopharm Animal Health Recent Developments/Updates

Table 85. Ceva PRRS Vaccines Company Information

Table 86. Ceva PRRS Vaccines Specification and Application

Table 87. Ceva PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Ceva Main Business and Markets Served

Table 89. Ceva Recent Developments/Updates

Table 90. Ruipu Biological PRRS Vaccines Company Information

Table 91. Ruipu Biological PRRS Vaccines Specification and Application

Table 92. Ruipu Biological PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Ruipu Biological Main Business and Markets Served

Table 94. Ruipu Biological Recent Developments/Updates

Table 95. Qilu Animal Health PRRS Vaccines Company Information

Table 96. Qilu Animal Health PRRS Vaccines Specification and Application

Table 97. Qilu Animal Health PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Qilu Animal Health Main Business and Markets Served

Table 99. Qilu Animal Health Recent Developments/Updates

Table 100. Dahuanong PRRS Vaccines Company Information

Table 101. Dahuanong PRRS Vaccines Specification and Application

Table 102. Dahuanong PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Dahuanong Main Business and Markets Served

Table 104. Dahuanong Recent Developments/Updates

Table 105. CAVAC PRRS Vaccines Company Information

Table 106. CAVAC PRRS Vaccines Specification and Application

Table 107. CAVAC PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. CAVAC Main Business and Markets Served

Table 109. CAVAC Recent Developments/Updates

Table 110. Komipharm PRRS Vaccines Company Information

Table 111. Komipharm PRRS Vaccines Specification and Application

Table 112. Komipharm PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Komipharm Main Business and Markets Served

Table 114. Komipharm Recent Developments/Updates

Table 115. Agrovet PRRS Vaccines Company Information

Table 116. Agrovet PRRS Vaccines Specification and Application

Table 117. Agrovet PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Agrovet Main Business and Markets Served

Table 119. Agrovet Recent Developments/Updates

Table 120. Bioveta PRRS Vaccines Company Information

Table 121. Bioveta PRRS Vaccines Specification and Application

Table 122. Bioveta PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 123. Bioveta Main Business and Markets Served

Table 124. Bioveta Recent Developments/Updates

Table 125. Jinyu PRRS Vaccines Company Information

Table 126. Jinyu PRRS Vaccines Specification and Application

Table 127. Jinyu PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 128. Jinyu Main Business and Markets Served

Table 129. Jinyu Recent Developments/Updates

Table 130. Phibro Animal Health PRRS Vaccines Company Information

Table 131. Phibro Animal Health PRRS Vaccines Specification and Application

Table 132. Phibro Animal Health PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 133. Phibro Animal Health Main Business and Markets Served

Table 134. Phibro Animal Health Recent Developments/Updates

Table 135. Tiankang PRRS Vaccines Company Information

Table 136. Tiankang PRRS Vaccines Specification and Application

Table 137. Tiankang PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 138. Tiankang Main Business and Markets Served

Table 139. Tiankang Recent Developments/Updates

Table 140. Zoetis PRRS Vaccines Company Information

Table 141. Zoetis PRRS Vaccines Specification and Application

Table 142. Zoetis PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 143. Zoetis Main Business and Markets Served

Table 144. Zoetis Recent Developments/Updates

Table 145. Yongshun Biological PRRS Vaccines Company Information

Table 146. Yongshun Biological PRRS Vaccines Specification and Application

Table 147. Yongshun Biological PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 148. Yongshun Biological Main Business and Markets Served

Table 149. Yongshun Biological Recent Developments/Updates

Table 150. Pulike Biological PRRS Vaccines Company Information

Table 151. Pulike Biological PRRS Vaccines Specification and Application

Table 152. Pulike Biological PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 153. Pulike Biological Main Business and Markets Served

Table 154. Pulike Biological Recent Developments/Updates

Table 155. Key Raw Materials Lists

Table 156. Raw Materials Key Suppliers Lists

Table 157. PRRS Vaccines Distributors List

Table 158. PRRS Vaccines Customers List

Table 159. PRRS Vaccines Market Trends

Table 160. PRRS Vaccines Market Drivers

Table 161. PRRS Vaccines Market Challenges

Table 162. PRRS Vaccines Market Restraints

Table 163. Research Programs/Design for This Report

Table 164. Key Data Information from Secondary Sources

Table 165. Key Data Information from Primary Sources

Table 166. Authors List of This Report

List of Figures

Figure 1. Product Picture of PRRS Vaccines

Figure 2. Global PRRS Vaccines Market Value by Type, (US$ Million) & (2020-2031)

Figure 3. Global PRRS Vaccines Market Share by Type: 2024 VS 2031

Figure 4. Live Vaccines Product Picture

Figure 5. Killed Vaccines Product Picture

Figure 6. Global PRRS Vaccines Market Value by Application, (US$ Million) & (2020-2031)

Figure 7. Global PRRS Vaccines Market Share by Application: 2024 VS 2031

Figure 8. Government Tender

Figure 9. Market Sales

Figure 10. Global PRRS Vaccines Production Value (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global PRRS Vaccines Production Value (US$ Million) & (2020-2031)

Figure 12. Global PRRS Vaccines Production Capacity (K Units) & (2020-2031)

Figure 13. Global PRRS Vaccines Production (K Units) & (2020-2031)

Figure 14. Global PRRS Vaccines Average Price (USD/Unit) & (2020-2031)

Figure 15. PRRS Vaccines Report Years Considered

Figure 16. PRRS Vaccines Production Share by Manufacturers in 2024

Figure 17. Global PRRS Vaccines Production Value Share by Manufacturers (2024)

Figure 18. PRRS Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 19. The Global 5 and 10 Largest Players: Market Share by PRRS Vaccines Revenue in 2024

Figure 20. Global PRRS Vaccines Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 21. Global PRRS Vaccines Production Value Market Share by Region: 2020 VS 2024 VS 2031

Figure 22. Global PRRS Vaccines Production Comparison by Region: 2020 VS 2024 VS 2031 (K Units)

Figure 23. Global PRRS Vaccines Production Market Share by Region: 2020 VS 2024 VS 2031

Figure 24. North America PRRS Vaccines Production Value (US$ Million) Growth Rate (2020-2031)

Figure 25. Europe PRRS Vaccines Production Value (US$ Million) Growth Rate (2020-2031)

Figure 26. China PRRS Vaccines Production Value (US$ Million) Growth Rate (2020-2031)

Figure 27. Japan PRRS Vaccines Production Value (US$ Million) Growth Rate (2020-2031)

Figure 28. Global PRRS Vaccines Consumption by Region: 2020 VS 2024 VS 2031 (K Units)

Figure 29. Global PRRS Vaccines Consumption Market Share by Region: 2020 VS 2024 VS 2031

Figure 30. North America PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 31. North America PRRS Vaccines Consumption Market Share by Country (2020-2031)

Figure 32. U.S. PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 33. Canada PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 34. Europe PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 35. Europe PRRS Vaccines Consumption Market Share by Country (2020-2031)

Figure 36. Germany PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 37. France PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 38. U.K. PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 39. Italy PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 40. Netherlands PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 41. Asia Pacific PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 42. Asia Pacific PRRS Vaccines Consumption Market Share by Region (2020-2031)

Figure 43. China PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 44. Japan PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 45. South Korea PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 46. China Taiwan PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 47. Southeast Asia PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 48. India PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 49. Latin America, Middle East & Africa PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 50. Latin America, Middle East & Africa PRRS Vaccines Consumption Market Share by Country (2020-2031)

Figure 51. Mexico PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 52. Brazil PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 53. Turkey PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 54. GCC Countries PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 55. Global Production Market Share of PRRS Vaccines by Type (2020-2031)

Figure 56. Global Production Value Market Share of PRRS Vaccines by Type (2020-2031)

Figure 57. Global PRRS Vaccines Price (USD/Unit) by Type (2020-2031)

Figure 58. Global Production Market Share of PRRS Vaccines by Application (2020-2031)

Figure 59. Global Production Value Market Share of PRRS Vaccines by Application (2020-2031)

Figure 60. Global PRRS Vaccines Price (USD/Unit) by Application (2020-2031)

Figure 61. PRRS Vaccines Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of PRRS Vaccines in 2031? zhanKai

The global market size of PRRS Vaccines in 2031 was 527 Million USD.

Which companies rank high in the global PRRS Vaccines market? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of PRRS Vaccines in 2025? shouQi

What is the annual compound growth rate of the global PRRS Vaccines market size from 2025 to 2031? shouQi

Related Reports

Global PRRS Vaccines Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global PRRS Vaccines market size was US$ 429 million in 2025 and is forecast to reach a readjusted size of US$ 543 million by 2032 with a CAGR of 3.5% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 104
USD 4250.00
(Single User License)
Global PRRS Vaccines Market Outlook, In‑Depth Analysis & Forecast to 2032
The global PRRS Vaccines market is projected to grow from US$ 429 million in 2025 to US$ 543 million by 2032, at a CAGR of 3.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 179
USD 4900.00
(Single User License)
PRRS Vaccines- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for PRRS Vaccines was estimated to be worth US$ 429 million in 2025 and is projected to reach US$ 543 million, growing at a CAGR of 3.5% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 131
USD 3950.00
(Single User License)
Global PRRS Vaccines Market Research Report 2026
The global PRRS Vaccines market was valued at US$ 429 million in 2025 and is anticipated to reach US$ 543 million by 2032, at a CAGR of 3.5% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 146
USD 2900.00
(Single User License)
Global PRRS Vaccines Market Outlook, In‑Depth Analysis & Forecast to 2031
The global PRRS Vaccines market is projected to grow from US$ 410 million in 2024 to US$ 527 million by 2031, at a CAGR of 3.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-30
Pages: 176
USD 4900.00
(Single User License)
PRRS Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for PRRS Vaccines was estimated to be worth US$ 410 million in 2024 and is forecast to a readjusted size of US$ 527 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
Published Date: 2025-05-23
Pages: 134
USD 3950.00
(Single User License)
Global PRRS Vaccines Market Insights, Forecast to 2031
The global PRRS Vaccines market is projected to grow from US$ 429 million in 2025 to US$ 527 million by 2031, at a Compound Annual Growth Rate (CAGR) of 3.5% during the forecast period.
Published Date: 2025-05-23
Pages: 175
USD 4900.00
(Single User License)
Global PRRS Vaccines Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global PRRS Vaccines market size was US$ 410 million in 2024 and is forecast to a readjusted size of US$ 527 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
Published Date: 2025-05-23
Pages: 109
USD 4250.00
(Single User License)
PRRS Vaccines- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for PRRS Vaccines was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 140
USD 3950.00
(Single User License)
Global PRRS Vaccines Market Insights, Forecast to 2030
There are two types of PRRS vaccines that are commercially available. One is a modified-live virus (MLV) vaccine and the other is a killed virus (KV) vaccine. PRRS MLV vaccine is well recognized for its protective efficacy against PRRSV that are genetically homologous to the vaccine virus.
Published Date: 2024-04-22
Pages: 117
USD 4900.00
(Single User License)

Global PRRS Vaccines Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global PRRS Vaccines market size was US$ 429 million in 2025 and is forecast to reach a readjusted size of US$ 543 million by 2032 with a CAGR of 3.5% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 104
USD 4250.00 (Single User License)
Global PRRS Vaccines Market Outlook, In‑Depth Analysis & Forecast to 2032
The global PRRS Vaccines market is projected to grow from US$ 429 million in 2025 to US$ 543 million by 2032, at a CAGR of 3.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 179
USD 4900.00 (Single User License)
PRRS Vaccines- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for PRRS Vaccines was estimated to be worth US$ 429 million in 2025 and is projected to reach US$ 543 million, growing at a CAGR of 3.5% from 2026 to 2032.
Published: 2026-03-05
Pages: 131
USD 3950.00 (Single User License)
Global PRRS Vaccines Market Research Report 2026
The global PRRS Vaccines market was valued at US$ 429 million in 2025 and is anticipated to reach US$ 543 million by 2032, at a CAGR of 3.5% from 2026 to 2032.
Published: 2026-03-05
Pages: 146
USD 2900.00 (Single User License)
Global PRRS Vaccines Market Outlook, In‑Depth Analysis & Forecast to 2031
The global PRRS Vaccines market is projected to grow from US$ 410 million in 2024 to US$ 527 million by 2031, at a CAGR of 3.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-30
Pages: 176
USD 4900.00 (Single User License)
PRRS Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for PRRS Vaccines was estimated to be worth US$ 410 million in 2024 and is forecast to a readjusted size of US$ 527 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
Published: 2025-05-23
Pages: 134
USD 3950.00 (Single User License)
Global PRRS Vaccines Market Insights, Forecast to 2031
The global PRRS Vaccines market is projected to grow from US$ 429 million in 2025 to US$ 527 million by 2031, at a Compound Annual Growth Rate (CAGR) of 3.5% during the forecast period.
Published: 2025-05-23
Pages: 175
USD 4900.00 (Single User License)
Global PRRS Vaccines Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global PRRS Vaccines market size was US$ 410 million in 2024 and is forecast to a readjusted size of US$ 527 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
Published: 2025-05-23
Pages: 109
USD 4250.00 (Single User License)
PRRS Vaccines- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for PRRS Vaccines was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 140
USD 3950.00 (Single User License)
Global PRRS Vaccines Market Insights, Forecast to 2030
There are two types of PRRS vaccines that are commercially available. One is a modified-live virus (MLV) vaccine and the other is a killed virus (KV) vaccine. PRRS MLV vaccine is well recognized for its protective efficacy against PRRSV that are genetically homologous to the vaccine virus.
Published: 2024-04-22
Pages: 117
USD 4900.00 (Single User License)